Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07606443 · ClinicalTrials.gov registry record · NA
COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07606443: Clinical Trial NA study, sponsored by Stanford University.
NCT07606443 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07606443, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.
Primary Outcome
Feasibility assessed by the proportion of invited dyads who enroll in the study.
Interventions
- BEHAVIORAL Family-Centered Communication Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-07 |
| Phase | NA |
What is known before NCT07606443 opens enrollment
NCT07606443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Family-Centered Communication Intervention is the first listed.
NCT07606443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07606443 about?
NCT07606443 is a clinical study titled "COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care". This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.
What is the current status of trial NCT07606443?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-07. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07606443?
The interventions under investigation include: Family-Centered Communication Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07606443?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07606443's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia